Molecular Test Listing

Molecular Requisition


MARFAN SYNDROME: DIRECT MUTATION DETECTION

Marfan disease is a result of defects in the connective protein fibrillin. This disorder results in individuals that can be very tall and thin, have pectus excavatum (depression under the sternum in chest), and develop cataracts and/or dislocated retinas. Defects in the aorta (mitral valve prolapse, aortic dilation, and aortic aneurysm) can be life threatening - especially for pregnant women. In the United States, it is estimated that 1 in 10,000 are at risk for developing Marfan disease. However, the risk may be much higher because many cases remain undiagnosed due to variable expression.

Most Marfan disease is inherited in an autosomal dominant pattern as the result of a defective fibrillin gene located on chromosome 15. However, a large proportion of cases appear spontaneous and variable expression can obscure the inheritance patterns. Therefore, direct testing for the mutations is often the only way to confirm the disease in many patients. Detection of mutations by sequencing of the fibrillin gene ranges from 35% to 85% depending on family history.

REASONS FOR REFERRAL:

  • Individuals with potential Marfan disease who want to assess the need for regular echocardiograms, and assess the risk of high stress physical activity such as competitive sports or pregnancy.
  • Individuals with potential Marfan disease who wish to undergo prenatal or preconception testing.
  • Individuals who are tall and have eye or heart problems.
  • Individuals with Marfan-like symptoms but no family history.

TESTING METHODOLOGY:

  • Analysis of the fibrillin (FBN1) gene is performed by either DNA sequencing using whole blood, or cDNA (RNA) sequencing using skin fibroblasts. DNA sequencing is offered as a complete analysis of all 65 exons and their associated intron junctions; or as an analysis of exons 24 through 32 for severe Neonatal Marfan syndrome. For further details click here.
    • The choice of testing strategy involves many factors. A discussion with the laboratory is recommended before sending a specimen.

    SPECIMEN REQUIREMENTS:

    • EDTA (purple top) tubes - Newborn: minimum 1 mL; Child/Adult: prefer 2 tubes of 3-5mL blood.

    • Live fibroblasts- either cultured or as a skin biopsy. Due to the sensitivity of the specimen, it is highly recommended that the cells be cultured by a facility as close to the collection site as possible. However if desired, the skin biopsy may be sent directly, and the culture will be grown at our facility. Please note that an additional cost will be incurred; add CPT code 88233 for this service.

  • Please contact the laboratory for instructions.
  • TURNAROUND TIMES:

         Complete gene analysis (DNA): 6 - 8 weeks

         Complete gene analysis (RNA): 6 - 8 weeks

         Neonatal Marfan DNA Analysis (exons 24-32): 3 weeks

    CPT CODES: